Geron (GERN) Shares Outstanding (2010 - 2026)
Geron's (GERN) quarterly Shares Outstanding came in at $641.0 million in Q1 2026, up 0.65% year-on-year from $636.9 million in Q1 2025, and little changed quarter-over-quarter from $639.9 million in Q4 2025.
Geron (GERN) Shares Outstanding (2010 - 2026) Analysis & Trends
Geron has disclosed Shares Outstanding across 17 years of filings, most recently posting $641.0 million for Q1 2026.
- Shares Outstanding for Q1 2026 came in at $641.0 million, up 0.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $641.0 million (up 0.65% YoY), and the FY2025 annual result was $639.9 million, up 5.52% from the prior year.
- Shares Outstanding came in at $641.0 million for Q1 2026 at Geron, roughly flat from $639.9 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $641.0 million in Q1 2026 to a low of $323.7 million in Q1 2022.
- The 5-year median for Shares Outstanding is $591.2 million (2024), against an average of $540.4 million.
- Across the five-year window, Shares Outstanding surged 57.14% in 2023 and rose 0.65% in 2026, its largest moves.
- Geron's Shares Outstanding stood at $390.3 million in 2022, then jumped by 39.63% to $544.9 million in 2023, then climbed by 11.28% to $606.4 million in 2024, then gained by 5.52% to $639.9 million in 2025, then advanced by 0.18% to $641.0 million in 2026.
- The last three Shares Outstanding figures came in at $641.0 million (Q1 2026), $639.9 million (Q4 2025), and $638.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Geron | 753,046.88 | 753,046.88 | - | 641.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 641.03 Mn |
| Mar 31, 2026 | 641.03 Mn |
| Mar 31, 2026 | 641.03 Mn |
| Mar 31, 2026 | 641.03 Mn |
| Mar 31, 2026 | 641.03 Mn |
| Mar 31, 2026 | 641.03 Mn |
| Mar 31, 2026 | 641.03 Mn |
| Mar 31, 2026 | 641.03 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Dec 31, 2025 | 639.86 Mn |
| Sep 30, 2025 | 638.36 Mn |
| Sep 30, 2025 | 638.36 Mn |
| Sep 30, 2025 | 638.36 Mn |
| Sep 30, 2025 | 638.36 Mn |